Review Article
Asia Oceania Guidelines for the Implementation of Programs for Cervical Cancer Prevention and Control
Table 2
Key elements to be considered in choosing a screening strategy for high-resources settings.
| Screening method | Cervical cytology or HPV DNA testing |
| Adjunct | HPV testing and colposcopy for abnormal cytology, colposcopy, and/or biopsy for those persistently HPV DNA(+) | Support | Colposcopy and treatment for CIN2+ and cancer | Age | Starting at 25 to 30 years old and ending at 65 years old | Interval | Once every 3 to 5 years | Screening Registry | Available | Cancer Registry | National, regional, and local level available |
|
|